190 related articles for article (PubMed ID: 21926608)
1. Differential effects of etomidate and its pyrrole analogue carboetomidate on the adrenocortical and cytokine responses to endotoxemia.
Pejo E; Feng Y; Chao W; Cotten JF; Le Ge R; Raines DE
Crit Care Med; 2012 Jan; 40(1):187-92. PubMed ID: 21926608
[TBL] [Abstract][Full Text] [Related]
2. Closed-loop continuous infusions of etomidate and etomidate analogs in rats: a comparative study of dosing and the impact on adrenocortical function.
Cotten JF; Le Ge R; Banacos N; Pejo E; Husain SS; Williams JH; Raines DE
Anesthesiology; 2011 Oct; 115(4):764-73. PubMed ID: 21572317
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro pharmacological studies of methoxycarbonyl-carboetomidate.
Pejo E; Cotten JF; Kelly EW; Le Ge R; Cuny GD; Laha JK; Liu J; Lin XJ; Raines DE
Anesth Analg; 2012 Aug; 115(2):297-304. PubMed ID: 21965364
[TBL] [Abstract][Full Text] [Related]
4. The pyrrole etomidate analog carboetomidate potently inhibits human 5-HT3A receptor function: comparisons with etomidate and potential implications for emetogenesis.
Desai R; Miller KW; Raines DE
Anesth Analg; 2013 Mar; 116(3):573-9. PubMed ID: 23400978
[TBL] [Abstract][Full Text] [Related]
5. Carboetomidate: a pyrrole analog of etomidate designed not to suppress adrenocortical function.
Cotten JF; Forman SA; Laha JK; Cuny GD; Husain SS; Miller KW; Nguyen HH; Kelly EW; Stewart D; Liu A; Raines DE
Anesthesiology; 2010 Mar; 112(3):637-44. PubMed ID: 20179500
[TBL] [Abstract][Full Text] [Related]
6. Carboetomidate: will it eliminate the etomidate debate?
Jackson WL
Crit Care Med; 2012 Jan; 40(1):333-4. PubMed ID: 22179369
[No Abstract] [Full Text] [Related]
7. Adrenocortical suppression and recovery after continuous hypnotic infusion: etomidate versus its soft analogue cyclopropyl-methoxycarbonyl metomidate.
Ge R; Pejo E; Cotten JF; Raines DE
Crit Care; 2013 Jan; 17(1):R20. PubMed ID: 23363638
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic studies on ET-26 hydrochloride in a rat model of lipopolysaccharide-induced sepsis.
Wang B; Jiang J; Yang J; Chen J; Zhu Z; Liu J; Zhang W
Eur J Pharm Sci; 2017 Nov; 109():441-445. PubMed ID: 28882766
[TBL] [Abstract][Full Text] [Related]
9. Sedative-hypnotic Binding to 11β-hydroxylase.
Pejo E; Zhou X; Husain SS; Raines DE
Anesthesiology; 2016 Nov; 125(5):943-951. PubMed ID: 27541316
[TBL] [Abstract][Full Text] [Related]
10. Cyclopropyl-methoxycarbonyl Metomidate: Studies in a Lipopolysaccharide Inflammatory Model of Sepsis.
Santer P; Pejo E; Feng Y; Chao W; Raines DE
Anesthesiology; 2015 Aug; 123(2):368-76. PubMed ID: 26035348
[TBL] [Abstract][Full Text] [Related]
11. Anesthetic Drug Discovery and Development: A Case Study of Novel Etomidate Analogs.
McGrath M; Raines DE
Methods Enzymol; 2018; 603():153-169. PubMed ID: 29673523
[TBL] [Abstract][Full Text] [Related]
12. An Etomidate Analogue With Less Adrenocortical Suppression, Stable Hemodynamics, and Improved Behavioral Recovery in Rats.
Wang B; Yang J; Chen J; Kang Y; Yang LH; Liu J; Zhang WS
Anesth Analg; 2017 Aug; 125(2):442-450. PubMed ID: 28514325
[TBL] [Abstract][Full Text] [Related]
13. Analogues of etomidate: modifications around etomidate's chiral carbon and the impact on in vitro and in vivo pharmacology.
Pejo E; Santer P; Jeffrey S; Gallin H; Husain SS; Raines DE
Anesthesiology; 2014 Aug; 121(2):290-301. PubMed ID: 24777068
[TBL] [Abstract][Full Text] [Related]
14. Methoxycarbonyl-etomidate: a novel rapidly metabolized and ultra-short-acting etomidate analogue that does not produce prolonged adrenocortical suppression.
Cotten JF; Husain SS; Forman SA; Miller KW; Kelly EW; Nguyen HH; Raines DE
Anesthesiology; 2009 Aug; 111(2):240-9. PubMed ID: 19625798
[TBL] [Abstract][Full Text] [Related]
15. Behavioral and steroidogenic pharmacology of phenyl ring substituted etomidate analogs in rats.
McGrath M; Hofmann A; Raines DE
BMC Pharmacol Toxicol; 2019 Aug; 20(1):48. PubMed ID: 31383012
[TBL] [Abstract][Full Text] [Related]
16. A Novel Etomidate Analog EL-0052 Retains Potent Hypnotic Effect and Stable Hemodynamics without Suppressing Adrenocortical Function.
Xu X; Wei Y; Dong Y; Qiu Y; Mei Z; Wang K; Xiu J; Wang T; Zeng L; Dong X; Shen Y; Jiang W; Li Q
J Pharmacol Exp Ther; 2021 Dec; 379(3):324-330. PubMed ID: 34521699
[TBL] [Abstract][Full Text] [Related]
17. Carboetomidate inhibits alpha4/beta2 neuronal nicotinic acetylcholine receptors at concentrations affecting animals.
Pierce DW; Pejo E; Raines DE; Forman SA
Anesth Analg; 2012 Jul; 115(1):70-2. PubMed ID: 22543065
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 is a needed proinflammatory cytokine in the prolonged neural activity and transcriptional activation of corticotropin-releasing factor during endotoxemia.
Vallières L; Rivest S
Endocrinology; 1999 Sep; 140(9):3890-903. PubMed ID: 10465257
[TBL] [Abstract][Full Text] [Related]
19. Advancing novel anesthetics: pharmacodynamic and pharmacokinetic studies of cyclopropyl-methoxycarbonyl metomidate in dogs.
Campagna JA; Pojasek K; Grayzel D; Randle J; Raines DE
Anesthesiology; 2014 Dec; 121(6):1203-16. PubMed ID: 25170571
[TBL] [Abstract][Full Text] [Related]
20. Carboetomidate: an analog of etomidate that interacts weakly with 11β-hydroxylase.
Shanmugasundararaj S; Zhou X; Neunzig J; Bernhardt R; Cotten JF; Ge R; Miller KW; Raines DE
Anesth Analg; 2013 Jun; 116(6):1249-56. PubMed ID: 23492967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
